Get the Stockscreener App
1.77
4.10%
0.08
Trinity Biotech Plc Adr stock is traded at $1.77, with a volume of 19,318.
It is up +4.10% in the last 24 hours and up +46.61% over the past month.
Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has two segments namely the Americas, and the Rest of World - Ireland from which it derives a majority of its revenue from the Americas segment.
See More
Previous Close:
$1.69
Open:
$1.69
24h Volume:
19,318
Relative Volume:
0.01
Market Cap:
$16.56M
Revenue:
$71.39M
Net Income/Loss:
$-28.60M
P/E Ratio:
-2.1906
EPS:
-0.808
Net Cash Flow:
$-12.92M
1W Performance:
-12.91%
1M Performance:
+46.61%
6M Performance:
-2.38%
1Y Performance:
-23.36%
1-Day Range:
$1.6259
$1.90
1-Week Range:
$1.62
$2.05
52-Week Range:
$1.0509
$3.55
Trinity Biotech Plc Adr Stock (TRIB) Company Profile
Name
Trinity Biotech Plc Adr
Sector
Industry
Phone
-
Address
-
Trinity Biotech Plc Adr Stock (TRIB) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-23-15 | Downgrade | Craig Hallum | Buy → Hold |
| Sep-03-15 | Initiated | Raymond James | Outperform |
| Jul-29-15 | Reiterated | ROTH Capital | Buy |
| Jul-22-08 | Reiterated | Roth Capital | Buy |
| Mar-17-08 | Reiterated | Roth Capital | Buy |
| Dec-10-07 | Reiterated | Roth Capital | Buy |
| Oct-26-07 | Reiterated | Roth Capital | Buy |
View All
Trinity Biotech Plc Adr Stock (TRIB) Latest News
European Equities Traded in the US as American Depositary Receipts Lower in Wednesday Trading - MSN
TRIBTrinity Biotech plc Latest Stock News & Market Updates - StockTitan
Trinity Biotech expands into oncology with EpiCapture buyout - Investing.com
Trinity Biotech invests in rapid sepsis diagnostics firm By Investing.com - Investing.com
Infectious Disease Diagnostics Market to Reach USD 43.09 Billion by 2031 | SkyQuest Technology - Benzinga
Trinity Biotech advances next-gen glucose monitor - Investing.com
Trinity Biotech acquires Metabolomics Diagnostics - Investing.com
TRIB underperforms with a -14.67 decrease in share price - US Post News
Balance Sheet Breakdown: Trinity Biotech Plc ADR (TRIB)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - The Dwinnex
Trinity Biotech to launch CGM tech in India, seeks feedback - Investing.com India
The United States Blood Testing Market Size & Outlook, 2030 - Grand View Research
Trinity Biotech names new Chief Commercial Officer - Investing.com
It is Poised to be a Bull Market for Trinity Biotech Plc ADR (TRIB) - SETE News
Market Recap: Trinity Biotech Plc ADR (TRIB)’s financial ratios: A comprehensive overview - The Dwinnex
Examining Trinity Biotech Plc ADR (TRIB) stock is warranted - US Post News
Trinity Biotech Plc ADR (TRIB) is looking forward to a strong quarter - SETE News
A Tale of Resilience: Trinity Biotech Plc ADR Amid Stock Market Turbulence - The InvestChronicle
Ratios Reveal: Breaking Down Trinity Biotech Plc ADR (TRIB)’s Financial Health - The Dwinnex
Martin Shkreli ordered to give up all copies of one-of-a-kind Wu-Tang Clan album - CNN
Trinity Biotech raises 2024 sales forecast for HIV test - Investing.com India
Li Auto Inc. Sponsored ADR (LI) Increases Despite Market Slip: Here's What You Need to Know - Yahoo Finance
Trinity Biotech appoints new biosensor marketing director - Investing.com India
Why PDD Holdings Inc. Sponsored ADR (PDD) Outpaced the Stock Market Today - Yahoo Finance
XPeng Inc. Sponsored ADR (XPEV) Laps the Stock Market: Here's Why - Yahoo Finance
Contrast Security Application Detection and Response (ADR) Praised by Industry Analysts for Addressing Gap in Cybersecurity Defenses - Yahoo Finance
Trinity Biotech gets extension to meet Nasdaq listing rules - Investing.com India
Li Auto Inc. Sponsored ADR (LI) Advances While Market Declines: Some Information for Investors - Yahoo Finance
XPeng Inc. Sponsored ADR (XPEV) Stock Declines While Market Improves: Some Information for Investors - Yahoo Finance
Trinity Biotech projects Q2 revenue growth, UK deal - Investing.com
Biotech Stock Roundup: BMY, GSK, BIIB's Q2 Results, VTVT Down on Setback - Yahoo Finance
Danaher (DHR) Q2 Earnings Beat, Biotechnology Sales Dip Y/Y - Yahoo Finance
Sea Limited Sponsored ADR (SE) Stock Declines While Market Improves: Some Information for Investors - Yahoo Finance
Legend Biotech (LEGN) Up 12% on Reports of Takeover Bid - Yahoo Finance
Silence Therapeutics (SLN) Moves 5.8% Higher: Will This Strength Last? - Yahoo Finance
Is Bayerische Motoren Werke AG Sponsored ADR (BMWYY) Stock Undervalued Right Now? - Yahoo Finance
Trinity Biotech appoints new CFO - Investing.com India
Trinity Biotech appoints new CFO By Investing.com - Investing.com
Kintara Therapeutics restructures share designations By Investing.com - Investing.com
Trinity Bio ADR (TRIB-Q) QuotePress Release - The Globe and Mail
European Equities Traded in the US as American Depositary Receipts Start Week Higher in Monday Trading - MSN
XPeng Inc. Sponsored ADR (XPEV) Outpaces Stock Market Gains: What You Should Know - Yahoo Finance
Biotech Stock Roundup: GSK's Litigation Update, BIIB's Drug Approval & Other Updates - Yahoo Finance
Why the Dow fell 1,000 points in the last three days - CNN
Earnings call: Trinity Biotech eyes growth with HIV test and CGM tech - Investing.com India
Earnings call: Trinity Biotech eyes growth with HIV test and CGM tech By Investing.com - Investing.com
Wall Street is about to see its biggest trading change in years - CNN
Is Bicycle Therapeutics (BCYC) Outperforming Other Medical Stocks This Year? - Yahoo Finance
Here's Why Vista Oil & Gas, S.A.B. de C.V. Sponsored ADR (VIST) Gained But Lagged the Market Today - Yahoo Finance
Trinity Biotech Plc Adr Stock (TRIB) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.55%
0.53%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):